Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07121413 |
| Consolidated Lead Sponsor | Shanghai Synvida Biotechnology Co |
| Therapeutic Condition Cohort | Respiratory and Pulmonary |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 48 participants (ESTIMATED) |
| Registered Start Date | 2025-11-04 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Sichuan Provincial People's Hospital | Chengdu, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, China | Open Hospital Dossier -> |
| Hangzhou First People's Hospital | Hangzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Nanchang University | Nanchang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.